Linker Information
General Information of This Linker
Linker ID |
LIN0VFZNC
|
|||||
---|---|---|---|---|---|---|
Linker Name |
Mc-PEG2
|
|||||
Linker Type |
Flexible reactive (thiol) linker
|
|||||
Antibody-Linker Relation |
Uncleavable
|
|||||
Structure | ||||||
Formula |
C16H27N3O5
|
|||||
Isosmiles |
C1=CC(=O)N(C1=O)CCCCCC(=O)NCCOCCOCCN
|
|||||
PubChem CID | ||||||
InChI |
InChI=1S/C16H27N3O5/c17-7-10-23-12-13-24-11-8-18-14(20)4-2-1-3-9-19-15(21)5-6-16(19)22/h5-6H,1-4,7-13,17H2,(H,18,20)
|
|||||
InChIKey |
BRPNMDKROWMZAK-UHFFFAOYSA-N
|
|||||
IUPAC Name |
N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-6-(2,5-dioxopyrrol-1-yl)hexanamide
|
|||||
Pharmaceutical Properties |
Molecule Weight
|
341.4
|
Polar area
|
111
|
||
Complexity
|
421
|
xlogp Value
|
-0.3
|
|||
Heavy Count
|
24
|
Rot Bonds
|
14
|
|||
Hbond acc
|
6
|
Hbond Donor
|
2
|
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
Alpha-CD22-HC-A140C-11 [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.03 nM
|
Positive CD22 expression (CD22+++/++) | ||
Method Description |
Seco-CBI-Dimer TDCs Exhibit Potent Antigen-Dependent Antiproliferation Effects in Vitro. All cell-based assay results are reported as the arithmetic mean of at least three separate runs (n = 3).
|
||||
In Vitro Model | Diffuse large B-cell lymphoma | WSU-DLCL2 cells | CVCL_1902 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.14 nM
|
Positive CD22 expression (CD22+++/++) | ||
Method Description |
Seco-CBI-Dimer TDCs Exhibit Potent Antigen-Dependent Antiproliferation Effects in Vitro. All cell-based assay results are reported as the arithmetic mean of at least three separate runs (n = 3).
|
||||
In Vitro Model | Burkitt lymphoma | BJAB cells | CVCL_5711 | ||
Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
17.00 nM
|
Positive CD22 expression (CD22+++/++) | ||
Method Description |
Seco-CBI-Dimer TDCs Exhibit Potent Antigen-Dependent Antiproliferation Effects in Vitro. All cell-based assay results are reported as the arithmetic mean of at least three separate runs (n = 3).
|
||||
In Vitro Model | T acute lymphoblastic leukemia | Jurkat cells | CVCL_0065 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.